The Phase IIa 12-week trial (approximately 300 obese adults, oral administration) produced a 2.6 kg weight loss at the 1 mg/day dose versus 0.8 kg in the placebo group [8]
TB-500 has been developed to leverage the benefits of thymosin beta-4, focusing on enhancing tissue regeneration, reducing inflammation, and promoting overall recovery
Its commonly chosen by those with active lifestyles or chronic inflammation
For larger groups like an entire team, we coordinate multiple nurses to get everyone recovered faster
Comparing 100mg to other vial sizes Is 100mg the right vial size for your needs
MOTS-c Mitochondrial Open Reading Frame of the Twelve-C, also known as MOTS-c, is a small mitochondrial peptide and one of the more recently studied